Clinical Trial Update: Exenatide for Smoking Cessation and Prevention of Weight Gain [Phase 2]

View source ↗

Summary

Phase 2 trial update shows completion of a study evaluating exenatide for smoking cessation and prevention of weight gain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Obesity

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Smoking Cessation, Weight Gain | Phase 2 | Status: COMPLETED